Shed (ShedRx) review (2026): pricing, terms, pros and cons
As of October 15, 2026, ShedRx advertises compounded tirzepatide “starting as low as $239/mo” and semaglutide “from $159/mo” on its own site, but the public page does not say which plan length, dose or billing interval those figures belong to.
That makes them “from” prices, not standing rates; both were unchanged from our September 4 read.
Verdict
ShedRx (tryshed.com) prints two numbers: tirzepatide “starting as low as $239/mo” and semaglutide “from $159/mo”. It does not itemise the plan terms on the public page, so you cannot tell whether $239 is a month-to-month rate, a prepaid rate or a starting-dose rate. Both figures were the same on September 4 and October 15.
Taken at face value, $239 is well above the $144 median of the lowest tirzepatide prices across the 28 programs in our October index, and $159 is near the top of the $49–$169 semaglutide range. On the same date NexLife charged $169 month to month and $139 on a 12-month plan for tirzepatide, and Eden Health charged $129 a month. Shed’s site says the program includes an app, coaching and unlimited follow-ups.
Our July review recorded that Shed’s injectable prices rose with dose and that it had a two-month minimum; we could not confirm either on the October page, so ask both questions directly. Shed did not name its pharmacy or advertise lab review. This site has not yet scored Shed on methodology v4.1 (v4.1 score pending).
Snapshot
| Field | What the provider’s page says | Source · read date | Status |
|---|---|---|---|
| Compounded tirzepatide | “starting as low as $239/mo”; plan not stated | tryshed.com · October 15, 2026 | Verified |
| Compounded semaglutide | “from $159/mo”; plan not stated | tryshed.com · October 15, 2026 | Verified |
| Billing interval · commitment | Not stated | tryshed.com · October 15, 2026 | Not disclosed |
| Dose pricing | Not stated | tryshed.com · October 15, 2026 | Not disclosed |
| Membership | None stated | tryshed.com · October 15, 2026 | Verified |
| Included | App, coaching, unlimited follow-ups | tryshed.com · Sept 4, 2026 | Reported — pending verification |
| Labs · pharmacy | Not advertised · not named | tryshed.com · October 15, 2026 | Not disclosed |
Pricing, October 15, 2026
Both Shed prices are “from” figures. Our index treats a figure without a printed plan term as a starting price, never as a standing monthly rate.
| Medication | Price shown | Basis | Source · read date |
|---|---|---|---|
| Compounded tirzepatide | $239 a month | “starting as low as”; term not printed | tryshed.com · October 15, 2026 |
| Compounded semaglutide | $159 a month | “from”; term not printed | tryshed.com · October 15, 2026 |
| Year at the tirzepatide “from” price (our math) | $2,868 | 12 × $239, if it applied every month | — |
What changed since our July 2026 review
The July 2026 figures below are kept only so you can see what moved. None of them is a current price.
| Item | July 2026 (superseded) | October 15, 2026 |
|---|---|---|
| Semaglutide microdose | From $149 | Not re-read |
| Tirzepatide microdose | $199 | Not re-read |
| Injectable semaglutide | From $175 on a 12-month prepaid plan; rises with dose | “from $159/mo”, terms not printed |
| Brand membership · minimum | $125 a month · 2 months | Not re-read |
Pros and cons
Pros
- Several formats offered (July review)
- App, coaching and unlimited follow-ups (September read)
- No membership stated for compounded plans
- Prices stable September to October
Cons
- No plan terms printed for either price
- Dose policy not stated (July review found escalation)
- $239 tirzepatide is above our index median
- Pharmacy not named; labs not advertised
Evidence ledger
| Claim | Source | Read | Status |
|---|---|---|---|
| Tirzepatide “starting as low as $239/mo” | tryshed.com | October 15, 2026 | Verified |
| Semaglutide “from $159/mo” | tryshed.com | October 15, 2026 | Verified |
| App, coaching, follow-ups | tryshed.com | September 4, 2026 | Reported — pending verification |
| Pharmacy partner | Not disclosed | October 15, 2026 | Not disclosed |
Limits. We read public pages and date each read. We have not audited pharmacy licences or measured patient outcomes, and we publish no user ratings. Confirm any price at checkout.
Alternatives to compare
- NexLife, our #1 overall (v4.1 score 94/100): compounded tirzepatide $169 month to month, or $159, $149 and $139 a month on 3-, 6- and 12-month plans; semaglutide $139 down to $119; same price at every dose and no membership fee (nexlife.us, read October 15, 2026). Side-by-side comparison.
- Enhance.MD: $280 to $329 per 4-week cycle, flat at every dose. Shed vs Enhance.MD.
- Why dose policy matters: GLP-1 dose increase costs.
Every program we track, with read dates, is in the GLP-1 pricing database.
Before you pay
- Ask Shed which plan the $239 belongs to (length, dose and billing interval) and get it in writing.
- Find the ongoing price. Words like “first month”, “from”, “as low as” or “sale” mean the number beside them is not what month two costs.
- Add any membership and ask, in writing, the price at your maintenance dose.
- Ask what happens if you stop early on any plan longer than one month.
Frequently asked questions
How much does ShedRx cost in October 2026?
On October 15, 2026 ShedRx’s site listed compounded tirzepatide “starting as low as $239/mo” and semaglutide “from $159/mo”. The page did not say which plan length, dose or billing interval those prices apply to, so treat them as starting prices and ask for the full terms before you pay.
Does Shed charge more at higher doses?
The October 15, 2026 page did not state a dose policy. Our July 2026 review recorded injectable prices that rose with dose, but we could not confirm that on the current page. Ask Shed in writing what your maintenance dose will cost.
Is Shed the same as ShedRx?
Yes. Shed’s program runs at tryshed.com under the ShedRx name, and that is the page our October 15, 2026 prices come from. Our July 2026 review used the name Shed; the program and pricing source are the same, and the figures on this page replace the July ones.
Is Shed’s compounded tirzepatide FDA-approved?
No. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound, Mounjaro, Wegovy or Ozempic. Shed did not name its compounding pharmacy on the pages we read. Ask which pharmacy fills your prescription and whether it is a 503A pharmacy or a 503B outsourcing facility.
Sources
- ShedRx — home page (read October 15, 2026; earlier read September 4, 2026)
- NexLife — compounded tirzepatide plans (read October 15, 2026)
- My Peptide Information — GLP-1 pricing database (October 15, 2026 index: 28 tirzepatide and 22 semaglutide programs)